EP
RCEL icon

Essential Partners’s Avita Medical RCEL Stock Holding History

Essential Partners’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$188 Sell
16
-417
-96% -$3.31K ﹤0.01% 2609
2026
Q2 		$1.79K Sell
433
-212
-33% -$914 ﹤0.01% 2015
2026
Q1 		$2.39K Buy
+645
New +$2.71K ﹤0.01% 1931
2025
Q4 		– Sell
-14
Closed -$72 – 2892
2025
Q3 		$72 Buy
+14
New +$73 ﹤0.01% 2529

Other funds holding RCEL

HCA
Harpswell Capital Advisors Yarmouth, Maine $152M AUM 8.39% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

Essential Partners's RCEL Position: Q3 2026 in Review

Essential Partners reduced its Avita Medical (RCEL) stake by 96% in Q3 2026, selling an estimated $3.31K and leaving 16 shares worth $188. The position accounts for ﹤0.01% of the portfolio, ranked #2609.

Essential Partners first reported a position in RCEL in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.39K in Q1 2026. 4 funds tracked by Wall St. Rank hold RCEL as of Q3 2026.

  • Essential Partners held 16 shares of Avita Medical worth $188 as of Q3 2026.
  • Essential Partners sold 417 Avita Medical shares in Q3 2026, an estimated $3.31K.
  • Avita Medical made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #2609 holding.
  • Essential Partners first reported a position in Avita Medical in Q3 2025 and has held it in 4 quarters since.
  • Essential Partners's Avita Medical position peaked at $2.39K in Q1 2026.
  • 4 funds tracked by Wall St. Rank held Avita Medical as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.